Clinical Trials
29
Trial Phases
4 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
FDDA Utilization Study (FDDAU)
- Conditions
- Fatigue
- First Posted Date
- 2023-05-17
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT05861492
- Locations
- 🇨🇭
QualiPro Schweiz AG, Kriens, Luzern, Switzerland
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2025-10-31
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05766839
- Locations
- 🇺🇸
Children's Hospital Colorado Site 84014, Aurora, Colorado, United States
🇺🇸UF Health Pediatric Multispecialty Center Site 84006, Jacksonville, Florida, United States
🇺🇸Miller School of Medicine, University of Miami Site 84003, Miami, Florida, United States
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 1195
- Registration Number
- NCT03888066
- Locations
- 🇺🇸
Investigator Site 11-080, Alexander City, Alabama, United States
🇺🇸Investigator Site 11-041, Huntsville, Alabama, United States
🇺🇸Investigator Site 11-153, Phoenix, Arizona, United States
Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
- First Posted Date
- 2017-03-22
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT03087058
- Locations
- 🇺🇸
Investigator Site 1107, Palo Alto, California, United States
🇺🇸Investigator Site 1101, Kansas City, Kansas, United States
🇺🇸Investigator Site 1103, Baltimore, Maryland, United States